Schöler N - Search Results

1

Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature.

Schöler N, Langer C, Döhner H, Buske C, Kuchenbauer F. Schöler N, et al. Exp Hematol. 2010 Dec;38(12):1126-30. doi: 10.1016/j.exphem.2010.10.004. Epub 2010 Oct 25. Exp Hematol. 2010. PMID: 20977925 Review.

2

Circulating microRNAs as biomarkers - True Blood?

Schöler N, Langer C, Kuchenbauer F. Schöler N, et al. Genome Med. 2011 Nov 23;3(11):72. doi: 10.1186/gm288. Genome Med. 2011. PMID: 22112937 Free PMC article.

3

Impact of serum storage conditions on microRNA stability.

Grasedieck S, Schöler N, Bommer M, Niess JH, Tumani H, Rouhi A, Bloehdorn J, Liebisch P, Mertens D, Döhner H, Buske C, Langer C, Kuchenbauer F. Grasedieck S, et al. Among authors: scholer n. Leukemia. 2012 Nov;26(11):2414-6. doi: 10.1038/leu.2012.106. Epub 2012 Apr 16. Leukemia. 2012. PMID: 22504138 No abstract available.

4

Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production.

Olbrich C, Schöler N, Tabatt K, Kayser O, Müller RH. Olbrich C, et al. Among authors: scholer n. J Pharm Pharmacol. 2004 Jul;56(7):883-91. doi: 10.1211/0022357023754. J Pharm Pharmacol. 2004. PMID: 15233867

5

Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages.

Schöler N, Hahn H, Müller RH, Liesenfeld O. Schöler N, et al. Int J Pharm. 2002 Jan 14;231(2):167-76. doi: 10.1016/s0378-5173(01)00882-1. Int J Pharm. 2002. PMID: 11755269

6

Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages.

Schöler N, Olbrich C, Tabatt K, Müller RH, Hahn H, Liesenfeld O. Schöler N, et al. Int J Pharm. 2001 Jun 19;221(1-2):57-67. doi: 10.1016/s0378-5173(01)00660-3. Int J Pharm. 2001. PMID: 11397567

7

Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.

Schöler N, Krause K, Kayser O, Müller RH, Borner K, Hahn H, Liesenfeld O. Schöler N, et al. Antimicrob Agents Chemother. 2001 Jun;45(6):1771-9. doi: 10.1128/AAC.45.6.1771-1779.2001. Antimicrob Agents Chemother. 2001. PMID: 11353624 Free PMC article.

8

Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages.

Schöler N, Zimmermann E, Katzfey U, Hahn H, Müller RH, Liesenfeld O. Schöler N, et al. J Microencapsul. 2000 Sep-Oct;17(5):639-50. doi: 10.1080/026520400417685. J Microencapsul. 2000. PMID: 11038122

9

Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages.

Schöler N, Zimmermann E, Katzfey U, Hahn H, Müller RH, Liesenfeld O. Schöler N, et al. Int J Pharm. 2000 Mar 10;196(2):235-9. doi: 10.1016/s0378-5173(99)00430-5. Int J Pharm. 2000. PMID: 10699726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters